GCA
ACHC icon

Genesee Capital Advisors’s Acadia Healthcare ACHC Stock Holding History

Genesee Capital Advisors’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,626
Closed -$2.19M – 87
2022
Q4 		$2.19M Sell
26,626
-2,030
-7% -$167K 1.63% 13
2022
Q3 		$2.24M Sell
28,656
-459
-2% -$36.7K 1.71% 14
2022
Q2 		$1.97M Sell
29,115
-5,158
-15% -$360K 1.38% 17
2022
Q1 		$2.25M Sell
34,273
-696
-2% -$40.4K 1.17% 23
2021
Q4 		$2.12M Buy
34,969
+145
+0.4% +$8.65K 1.01% 32
2021
Q3 		$2.22M Buy
+34,824
New +$2.2M 1.1% 26

Other funds holding ACHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Genesee Capital Advisors's ACHC Position: Q1 2023 in Review

Genesee Capital Advisors sold out of Acadia Healthcare (ACHC) in Q1 2023, closing a stake of 26,626 shares — an estimated $2.19M sold.

Genesee Capital Advisors first reported a position in ACHC in Q3 2021 and held it in 6 quarters. The position peaked at $2.25M in Q1 2022. 310 funds tracked by Wall St. Rank hold ACHC as of Q1 2023.

  • Genesee Capital Advisors reported no remaining Acadia Healthcare position as of Q1 2023 after selling out during the quarter.
  • Genesee Capital Advisors sold 26,626 Acadia Healthcare shares in Q1 2023, an estimated $2.19M.
  • Genesee Capital Advisors first reported a position in Acadia Healthcare in Q3 2021 and held it in 6 quarters.
  • Genesee Capital Advisors's Acadia Healthcare position peaked at $2.25M in Q1 2022.
  • 310 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2023.

Based on Genesee Capital Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.